相关实验视频

Updated: Jul 29, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

脂肪肝疾病/非酒精性脂肪肝疾病的精准医学

Laura Valenzuela-Vallejo¹, Despina Sanoudou^2,3,4, Christos S Mantzoros^1,5

¹Department of Medicine, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

Journal of personalized medicine

|May 27, 2023

概括

非酒精性脂肪肝 (NAFLD) 需要更好的诊断和治疗. 与代谢相关的FLD (MAFLD) 一样,一种新的精准医学方法具有分类,旨在改善患者的护理和结果.

科学领域:

肝病学和胃肠病学肝病学和胃肠学
精准医学是一门精准的医学.
代谢障碍代谢障碍代谢障碍

背景情况:

非酒精性脂肪性肝病 (NAFLD) 是最常见的慢性肝病.
NAFLD与严重的肝脏,代谢和心血管并发症有关.
目前对NAFLD的诊断和治疗仍然是重大的临床挑战.

研究的目的:

为满足对NAFLD的非侵入性诊断和有效治疗的未满足需求.
为脂肪肝疾病 (FLD) 提出基于病理生理学的分类.
引入精准医学方法,以改善患者护理和FLD的结果.

主要方法:

为脂肪肝病 (FLD) 制定一个新的分类框架.
包括诸如代谢相关的FLD (MAFLD),遗传相关的FLD (GAFLD) 等子类别.
准确医学策略应用于FLD管理.

主要成果:

拟议的分类旨在更好地了解FLD的异质性.
预计这种方法将促进更有针对性和更有效的治疗.
预计患者护理,生活质量和长期疾病结果的改善.

结论:

精准医学方法,通过精细的FLD分类来支持,对于推进患者护理至关重要.
这一战略有可能减少长期疾病并发症和医疗保健成本.
预计未来的发展将为FLD提供更有针对性的治疗方法.

关键词:

脂肪肝疾病 (FLD) 是一种肝脏疾病.遗传学遗传学遗传学是一个代谢相关的脂肪肝疾病 (MAFLD)代谢代谢代谢代谢非酒精性脂肪肝疾病 (NAFLD) 是一种非酒精性脂肪肝疾病.非酒精性脂肪肝炎 (NASH) 是一种非酒精性脂肪肝炎.精准医学是一门精准医学.

更多相关视频

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

相关概念视频

Ultrasound II: Endoscopic Ultrasound and FibroScan

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...